National and Kapodistrian University of Athens
Η γενετική αρχιτεκτονική των εκ γενετής ανατομικών και νευρο-αναπτυξιακών διαταραχών
Abstract
dc:descriptionIntroduction: Neurodevelopmental diseases are a general category of diseases that are associated withimpaired development and proper functioning of the brain and have a negative impact on the mental andbehavioral function of patients. These diseases show great clinical and genetic heterogeneity as they includesyndromic and non-syndromic forms, often indistinguishable that make clinical genetic assessment anddiagnosis difficult. As a result, many of these cases remain undiagnosed and require further investigation.Utilization of new technologies such as genomic comparative hybridization (array-CGH) microarray technologyas well as next generation sequencing have helped to detect subchromosomal genomic rearrangements andpoint mutations and to identify novel genes and variants. At the same time, the use of experimental animalmodels, such as the zebrafish, has been shown to contribute significantly to the understanding of molecular andcellular processes associated with the occurrence of specific phenotypes and to characterize the pathogenesisof mutations detected in patients.Aim of the study: The present study focuses on the genetic investigation of patients with neurodevelopmentaland congenital diseases, utilizing technologies such as genomic comparative hybridization microarray analysis(array-CGH) and the next generation Sequencing (Whole Exome). At the same time, in collaboration withinternationally recognized Universities abroad, the experimental animal model zebrafish was used to model rarecases of patients with neurodevelopmental diseases.Materials and methods: The first part of the study focused on a cohort of 97 patients with complexneurodevelopmental and congenital diseases, such as changes in head size (microcephaly, or macrocephaly),in combination with other neurodevelopmental symptoms. For the first part of the study, the analysis of genomiccomparative hybridization microarrays (array-CGH) and the next generation sequencing (Whole ExomeSequencing) were used. The second part of the study, focused on 2 male siblings with mental retardation,macrocephaly and joint problem. For the second part of the study, the experimental zebrafish animal model wasused to model the mutations detected in both patients. The third part of the study focused on 7 patients fromthree different families, clinical features such as intestinal dysfunction and neurological symptoms that refer to adiagnosis of mitochondrial neuro-intestinal brain-myopathy. For the third part of the study, the zebrafishexperimental model and cytological methodologies were used to study mitochondrial function to identify a newcandidate gene associated with the appearance of phenotypes in patients.Results: In the first part of the study, chromosomal microarray analysis led to the detection of pathological andunknown CNVs in 31/75 subjects (41%). Of the 45 CNVs detected, 29/45 (64%) related to deletions, 15/45 (33%)related to simple duplications, while in one case 1/45 (2%) triplication of a region was observed. In 13/75individuals (17%) CNVs were classified as pathogenic and in 18/75 individuals (24%) were identified as ofunknown clinical significance and require further investigation. At the same time, next-generation sequencingdetected abnormal or potentially abnormal mutations in genes associated with the development of aneurodevelopmental syndrome in 39/95 individuals (40.43%), while in 2/95 individuals (2%) mutations ofunknown clinical nature were observed. important in genes that cause a neurodevelopmental syndrome. On theother hand, in 27/95 individuals (28.7%) up until the preparation of the present study, no mutation was detectedin a gene recorded to lead to a known neurodevelopmental syndrome and thus were recorded as negative.In the second part of the study, utilization of quad-based whole-exome sequencing technology allowed theidentification of the non-synonymous variant p.R79K in the DDX3X gene in a family, with 2 siblins. The variantwas detected in the sample of both affected siblings, while the genetic analysis confirmed that the mutation wasinherited from the asymptomatic mother (maternal origin), while no other pathological finding was identified.Then, to examine the possible correlation of the mutation with the phenotype of the patients, we used theexperimental model danio rerio (zebrafish). A study of the functionality of DDX3X with zebrafish showed that thep.R79K mutation leads to loss of function and is hypomorphic.The third part of the study involved 7 patients from three different families with clinical findings such as intestinaldysfunction and neurological symptoms suggestive of a diagnosis of mitochondrial neuro-enteric brainmyopathy.Analysis of genome DNA coding regions by next-generation (Whole exome sequencing) detected mutations ina new gene, LIG3, which has not been identified as responsible for the onset of a disease. Utilization of in vitromethodologies on fibroblast cells, isolated from patients showed reduced levels of LIG3 protein and reducedligase activity. At the same time, LIG3 dysfunction had a negative effect on the maintenance of mitochondrialDNA, resulting in reduced mitochondrial DNA levels, but without the presence of multiple deficienciescharacteristic of other mitochondrial diseases. Thus, it is possible that the observed mitochondrial dysfunction isresponsible for the observed pathology in these patients. In vivo functional studies using the experimental modeldanio rerio (zebrafish) showed that lig3 dysfunction can lead to pathological phenotypes of the brain andintestine, similar to those observed in patients.Discussion / Conclusions: Utilizing modern genomic technologies such as array-CGH microarrays and nextgeneration Whole Exome Sequencing allows for faster and more comprehensive analysis of the genome, betterphenotype / genotype correlations and therefore more accurate and comprehensive diagnosis. Where possible,the use of in vitro methodologies to further investigate of the molecular mechanisms associated with observedphenotypes, as well as experimental animal models such as the zebrafish, can help identify new genes andbetter characterize mutations detected in them.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kellaris, Georgios
- Κελλάρης, Γεώργιος
Subjects
dc:subject × 8Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/50657